{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T07:10:06Z","timestamp":1775459406400,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T00:00:00Z","timestamp":1617840000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","award":["Private University Branding Project"],"award-info":[{"award-number":["Private University Branding Project"]}],"id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Bone Miner Metab"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1007\/s00774-021-01223-4","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T16:02:20Z","timestamp":1617897740000},"page":"737-747","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":14,"title":["Persistent bone resorption lacunae on necrotic bone distinguish bisphosphonate-related osteonecrosis of jaw from denosumab-related osteonecrosis"],"prefix":"10.1007","volume":"39","author":[{"given":"Kazumitsu","family":"Aoki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoru","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichirou","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiko","family":"Shibahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Nomura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideo","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichi","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8649-0850","authenticated-orcid":false,"given":"Akira","family":"Yamaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,4,8]]},"reference":[{"key":"1223_CR1","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/S0140-6736(10)62344-6","volume":"377","author":"K Fizazi","year":"2011","unstructured":"Fizazi K, Carducci M, Smith M, Dami\u00e3o R, Brown J et al (2011) Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study. Lancet 377:813\u2013822","journal-title":"Lancet"},{"key":"1223_CR2","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell RG (2011) Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 48:677\u2013692","journal-title":"Bone"},{"key":"1223_CR3","doi-asserted-by":"publisher","first-page":"115493","DOI":"10.1016\/j.bone.2020.115493","volume":"139","author":"MJ Rogers","year":"2020","unstructured":"Rogers MJ, Monkkonen J, Munoz MA (2020) Molecular mechanisms of action of bisphosphonates and new insights into their effects outside the skeleton. Bone 139:115493","journal-title":"Bone"},{"key":"1223_CR4","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1038\/nrd3705","volume":"11","author":"DL Lacey","year":"2012","unstructured":"Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC et al (2012) Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov 11:401\u2013419","journal-title":"Nat Rev Drug Discov"},{"key":"1223_CR5","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1002\/jbmr.3376","volume":"33","author":"G Cai","year":"2018","unstructured":"Cai G, Laslett LL, Aitken D, Halliday A, Pan F et al (2018) Effect of zoledronic acid and denosumab in patients with low back pain and modic change: a proof-of-principle trial. J Bone Miner Res 33:773\u2013782","journal-title":"J Bone Miner Res"},{"key":"1223_CR6","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61:1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"key":"1223_CR7","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1016\/j.bjoms.2009.08.030","volume":"48","author":"KH Taylor","year":"2010","unstructured":"Taylor KH, Middlefell LS, Mizen KD (2010) Osteonecrosis of the jaws induced by anti-RANK ligand therapy. Br J Oral Maxillofac Surg 48:221\u2013223","journal-title":"Br J Oral Maxillofac Surg"},{"key":"1223_CR8","doi-asserted-by":"publisher","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero SL, Dodson TB, Fantasia J, Goodday R, Aghaloo T et al (2014) American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw\u20132014 update. J Oral Maxillofac Surg 72:1938\u20131956","journal-title":"J Oral Maxillofac Surg"},{"key":"1223_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s00774-016-0810-7","volume":"35","author":"T Yoneda","year":"2017","unstructured":"Yoneda T, Hagino H, Sugimoto T, Ohta H, Takahashi S et al (2017) Antiresorptive agent-related osteonecrosis of the jaw: position paper 2017 of the Japanese Allied Committee on Osteonecrosis of the Jaw. J Bone Miner Metab 35:6\u201319","journal-title":"J Bone Miner Metab"},{"key":"1223_CR10","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1111\/odi.12708","volume":"24","author":"K McGowan","year":"2018","unstructured":"McGowan K, McGowan T, Ivanovski S (2018) Risk factors for medication-related osteonecrosis of the jaws: a systematic review. Oral Dis 24:527\u2013536","journal-title":"Oral Dis"},{"key":"1223_CR11","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1007\/s00428-006-0261-y","volume":"449","author":"T Hansen","year":"2006","unstructured":"Hansen T, Kirkpatrick CJ, Walter C, Kunkel M (2006) Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate-associated osteonecrosis\u2013a paradoxical observation? Virchows Arch 449:448\u2013454","journal-title":"Virchows Arch"},{"key":"1223_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-0714.2006.00391.x","volume":"35","author":"T Hansen","year":"2006","unstructured":"Hansen T, Kunkel M, Weber A, James Kirkpatrick C et al (2006) Osteonecrosis of the jaws in patients treated with bisphosphonates - histomorphologic analysis in comparison with infected osteoradionecrosis. J Oral Pathol Med 35:155\u2013160","journal-title":"J Oral Pathol Med"},{"key":"1223_CR13","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.ijom.2011.12.016","volume":"41","author":"RE Marx","year":"2012","unstructured":"Marx RE, Tursun R (2012) Suppurative osteomyelitis, bisphosphonate induced osteonecrosis, osteoradionecrosis: a blinded histopathologic comparison and its implications for the mechanism of each disease. Int J Oral Maxillofac Surg 41:283\u2013289","journal-title":"Int J Oral Maxillofac Surg"},{"key":"1223_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.bone.2009.05.008","volume":"45","author":"G Favia","year":"2009","unstructured":"Favia G, Pilolli GP, Maiorano E (2009) Histologic and histomorphometric features of bisphosphonate-related osteonecrosis of the jaws: an analysis of 31 cases with confocal laser scanning microscopy. Bone 45:406\u2013413","journal-title":"Bone"},{"key":"1223_CR15","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1111\/jop.12156","volume":"43","author":"S Koerdt","year":"2014","unstructured":"Koerdt S, Dax S, Grimaldi H, Ristow O, Kuebler AC et al (2014) Histomorphologic characteristics of bisphosphonate-related osteonecrosis of the jaw. J Oral Pathol Med 43:448\u2013453","journal-title":"J Oral Pathol Med"},{"key":"1223_CR16","doi-asserted-by":"publisher","first-page":"452737","DOI":"10.1155\/2014\/452737","volume":"2014","author":"AM Hinson","year":"2014","unstructured":"Hinson AM, Smith CW, Siegel ER, Stack BC Jr et al (2014) Is bisphosphonate-related osteonecrosis of the jaw an infection? A histological and microbiological ten-year summary. Int J Dent 2014:452737","journal-title":"Int J Dent"},{"key":"1223_CR17","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1016\/j.oooo.2014.04.017","volume":"118","author":"E Franco-Pretto","year":"2014","unstructured":"Franco-Pretto E, Pacheco M, Moreno A, Messa O, Gnecco J et al (2014) Bisphosphonate-induced osteonecrosis of the jaws: clinical, imaging, and histopathology findings. Oral Surg Oral Med Oral Pathol Oral Radiol 118:408\u2013417","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1223_CR18","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.oooo.2016.09.225","volume":"123","author":"SM Kim","year":"2017","unstructured":"Kim SM, Eo MY, Kim YS, Lee SK et al (2017) Histochemical observation of bony reversal lines in bisphosphonate-related osteonecrosis of the jaw. Oral Surg Oral Med Oral Pathol Oral Radiol 123:220\u2013228","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1223_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s12967-017-1230-8","volume":"15","author":"C Gross","year":"2017","unstructured":"Gross C, Weber M, Creutzburg K, Mobius P, Preidl R et al (2017) Osteoclast profile of medication-related osteonecrosis of the jaw secondary to bisphosphonate therapy: a comparison with osteoradionecrosis and osteomyelitis. J Transl Med 15:128","journal-title":"J Transl Med"},{"key":"1223_CR20","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.jcms.2017.01.013","volume":"45","author":"S Hoefert","year":"2017","unstructured":"Hoefert S, Yuan A, Munz A, Grimm M, Elayouti A et al (2017) Clinical course and therapeutic outcomes of operatively and non-operatively managed patients with denosumab-related osteonecrosis of the jaw (DRONJ). J Craniomaxillofac Surg 45:570\u2013578","journal-title":"J Craniomaxillofac Surg"},{"key":"1223_CR21","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3892\/mco.2015.696","volume":"4","author":"Y Matsushita","year":"2016","unstructured":"Matsushita Y, Hayashida S, Morishita K, Sakamoto H, Naruse T et al (2016) Denosumab-associated osteonecrosis of the jaw affects osteoclast formation and differentiation: pathological features of two cases. Mol Clin Oncol 4:191\u2013194","journal-title":"Mol Clin Oncol"},{"key":"1223_CR22","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.oooo.2019.08.018","volume":"129","author":"A Yuan","year":"2020","unstructured":"Yuan A, Munz A, Reinert S, Hoefert S et al (2020) Histologic analysis of medication-related osteonecrosis of the jaw compared with antiresorptive-exposed bone and other infectious, inflammatory, and necrotic jaw diseases. Oral Surg Oral Med Oral Pathol Oral Radiol 129:133\u2013140","journal-title":"Oral Surg Oral Med Oral Pathol Oral Radiol"},{"key":"1223_CR23","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1679\/aohc.68.103","volume":"68","author":"S Ren","year":"2005","unstructured":"Ren S, Takano H, Abe K (2005) Two types of bone resorption lacunae in the mouse parietal bones as revealed by scanning electron microscopy and histochemistry. Arch Histol Cytol 68:103\u2013113","journal-title":"Arch Histol Cytol"},{"key":"1223_CR24","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1056\/NEJMoa0802633","volume":"360","author":"RS Weinstein","year":"2009","unstructured":"Weinstein RS, Roberson PK, Manolagas SC (2009) Giant osteoclast formation and long-term oral bisphosphonate therapy. N Engl J Med 360:53\u201362","journal-title":"N Engl J Med"},{"key":"1223_CR25","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1038\/nrrheum.2009.87","volume":"5","author":"N Jain","year":"2009","unstructured":"Jain N, Weinstein RS (2009) Giant osteoclasts after long-term bisphosphonate therapy: diagnostic challenges. Nat Rev Rheumatol 5:341\u2013346","journal-title":"Nat Rev Rheumatol"},{"key":"1223_CR26","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1172\/JCI119668","volume":"100","author":"PM Chavassieux","year":"1997","unstructured":"Chavassieux PM, Arlot ME, Reda C, Wei L, Yates AJ et al (1997) Histomorphometric assessment of the long-term effects of alendronate on bone quality and remodeling in patients with osteoporosis. J Clin Invest 100:1475\u20131480","journal-title":"J Clin Invest"},{"key":"1223_CR27","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s00198-003-1530-0","volume":"15","author":"RR Recker","year":"2014","unstructured":"Recker RR, Weinstein RS, Chesnut CH, Schimmer RC, Mahoney P et al (2014) Histomorphometric evaluation of daily and intermittent oral ibandronate in women with postmenopausal osteoporosis: results from the BONE study. Osteoporos Int 15:231\u2013237","journal-title":"Osteoporos Int"},{"key":"1223_CR28","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1210\/jc.2017-02669","volume":"103","author":"DW Dempster","year":"2018","unstructured":"Dempster DW, Brown JP, Fahrleitner-Pammer A, Kendler D, Rizzo S et al (2018) Effects of long-term denosumab on bone histomorphometry and mineralization in women with postmenopausal osteoporosis. J Clin Endocrinol Metab 103:2498\u20132509","journal-title":"J Clin Endocrinol Metab"},{"key":"1223_CR29","doi-asserted-by":"publisher","first-page":"1291","DOI":"10.1097\/AOG.0b013e318291718c","volume":"121","author":"C Recknor","year":"2013","unstructured":"Recknor C, Czerwinski E, Bone HG, Bonnick SL, Binkley N et al (2013) Denosumab compared with ibandronate in postmenopausal women previously treated with bisphosphonate therapy: a randomized open-label trial. Obstet Gynecol 121:1291\u20131299","journal-title":"Obstet Gynecol"},{"key":"1223_CR30","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1080\/17843286.2017.1348001","volume":"73","author":"T Loyson","year":"2018","unstructured":"Loyson T, Van Cann T, Schoffski P, Clement PM, Bechter O et al (2018) Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab. Acta Clin Belg 73:100\u2013109","journal-title":"Acta Clin Belg"},{"key":"1223_CR31","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1111\/jop.13112","volume":"50","author":"A Mamilos","year":"2020","unstructured":"Mamilos A, Sp\u00f6rl S, Spanier G, Ettl T, Brochhausen C et al (2020) The first quantitative histomorphological analyses of bone vitality and inflammation in surgical specimens of patients with medication-related osteonecrosis of the jaw. J Oral Pathol Med 50:76\u201384","journal-title":"J Oral Pathol Med"}],"container-title":["Journal of Bone and Mineral Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-021-01223-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00774-021-01223-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00774-021-01223-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,30]],"date-time":"2021-08-30T03:29:02Z","timestamp":1630294142000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00774-021-01223-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,8]]},"references-count":31,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["1223"],"URL":"https:\/\/doi.org\/10.1007\/s00774-021-01223-4","relation":{},"ISSN":["0914-8779","1435-5604"],"issn-type":[{"value":"0914-8779","type":"print"},{"value":"1435-5604","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,8]]},"assertion":[{"value":"9 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 April 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Ethics Committee of Tokyo Metropolitan Bokutoh Hospital (approval number: 29-64), Tokyo Dental College (approval number:850), and Ichikawa General Hospital Tokyo Dental College (approval number: I-19-59).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}